Key Tech vs Phillips-Medisize: full comparison for 2026
Quick verdict
Key Tech (4.3/5) edges ahead of Phillips-Medisize (3.9/5) overall. Key Tech is the better choice for IVD instruments with consumables. Phillips-Medisize is the stronger option for drug delivery devices needing high-volume production. The right choice depends on your project size, budget, and required tech stack.
Key Tech vs Phillips-Medisize: head-to-head summary
| Criterion | Key Tech | Phillips-Medisize |
|---|---|---|
| Founded | 1998 | 1964 |
| HQ | Baltimore, MD, USA | Hudson, WI, USA |
| Team size | 75–150 | ~7,000 |
| Rating | 4.3 / 5 | 3.9 / 5 |
| Primary differentiator | Designs the diagnostic instrument and its cartridge together, with human factors in the same studio | Design, molding and assembly of drug delivery devices under one global quality system |
| Pricing model | Time and materials, phased fixed project | Development contract plus manufacturing supply agreement |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | Embedded C/C++, Microfluidics, SolidWorks | Injection molding, Automated assembly, BLE |
| Industries served | Diagnostics & lab devices, Drug delivery, Surgical & therapeutic devices | Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices |
Key Tech vs Phillips-Medisize: overview
Key Tech
Key Tech (Key Technologies Inc.) was founded in 1998 in Baltimore, Maryland. It is ISO 13485 certified and works on medical device development, in vitro diagnostic instruments and consumables, drug delivery systems and human factors engineering, with an earlier client list that includes Becton Dickinson, GE, Thermo Fisher and Abiomed. Co-founder Jenny Regan handed the CEO role to Alex Flamm. The most recent public headcount we found was around 75 designers and engineers, which may now be higher.
Phillips-Medisize
Phillips-Medisize is a subsidiary of Molex, itself owned by Koch Industries, and provides outsourced design, development and manufacturing to pharma, diagnostics and medical device companies. It is based in Wisconsin and has about 7,000 employees. Molex's purchase of inhalation specialist Vectura added combination-product expertise, and the combined team includes more than 1,200 engineers and scientists across 30 sites. A $110M manufacturing campus in Katowice, Poland, opened in November 2023.
Services and capabilities: Key Tech vs Phillips-Medisize
| Capability | Key Tech | Phillips-Medisize |
|---|---|---|
| Electronics & PCB design | ✓ | ✓ |
| Firmware & embedded software | ✓ | ✗ |
| SaMD & companion apps | ✗ | ✗ |
| Connected devices & IoT | ✗ | ✗ |
| Industrial design & human factors | ✓ | ✗ |
| Mechanical engineering | ✓ | ✓ |
| Device cybersecurity | ✗ | ✗ |
| Regulatory & QMS support | ✗ | ✓ |
| Manufacturing & scale-up | ✗ | ✓ |
Tech stack comparison: Key Tech vs Phillips-Medisize
| Framework / platform | Key Tech | Phillips-Medisize |
|---|---|---|
| Embedded C/C++ | ✓ | N/A |
| Embedded Linux | N/A | N/A |
| RTOS | N/A | N/A |
| BLE | N/A | ✓ |
| Cloud (AWS/Azure) | N/A | N/A |
| IEC 62304 | N/A | N/A |
| ISO 14971 | N/A | N/A |
| ISO 13485 QMS | ✓ | ✓ |
| Qt | N/A | N/A |
Pricing comparison: Key Tech vs Phillips-Medisize
| Criterion | Key Tech | Phillips-Medisize |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Fixed project, Time & materials | Fixed project, Manufacturing contract |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: Key Tech vs Phillips-Medisize
| Dimension | Key Tech | Phillips-Medisize |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Diagnostics & lab devices, Drug delivery, Surgical & therapeutic devices | Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices |
| Best use cases | Developing a point-of-care molecular diagnostic instrument and cartridge, Usability testing for a drug delivery device | Autoinjector or pen injector development and production, Inhaler device for a pharma combination product |
| Typical project type | Fixed project | Fixed project |
Key Tech vs Phillips-Medisize: pros and cons
| Key Tech | |
|---|---|
| + | Strong record in diagnostics where instrument, consumable and assay have to be developed together |
| + | ISO 13485 certified quality system |
| + | Human factors and usability engineering are in-house |
| + | Named work with large medtech and life science companies |
| - | Public headcount data is dated, so confirm team capacity for large programs |
| - | No volume manufacturing |
| - | Little public evidence of SaMD or cloud platform work |
| Phillips-Medisize | |
|---|---|
| + | Very large manufacturing footprint across the US, Europe and Asia |
| + | Vectura deal added deep inhalation and combination-product skills |
| + | Development and manufacturing under one quality system |
| + | Experience with connected drug delivery |
| - | Owned by Molex and Koch Industries, so it suits large pharma more than small startups |
| - | Development work is usually tied to a manufacturing agreement |
| - | Less suited to software-heavy or early research projects |
Who should choose Key Tech?
A typical fit: developing a point-of-care molecular diagnostic instrument and cartridge.
Designs the diagnostic instrument and its cartridge together, with human factors in the same studio. Minimum engagement is not publicly disclosed. Works best with clients in Diagnostics & lab devices, Drug delivery, Surgical & therapeutic devices.
Who should choose Phillips-Medisize?
A typical fit: autoinjector or pen injector development and production.
Design, molding and assembly of drug delivery devices under one global quality system. Minimum engagement is not publicly disclosed. Works best with clients in Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices.
Decision matrix: Key Tech vs Phillips-Medisize
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | Key Tech |
| You need a large dedicated team for an ongoing programme | Check each company's engagement model |
| Your budget is at the lower end | Compare: Key Tech (Not disclosed) vs Phillips-Medisize (Not disclosed) |
| You need specialist depth in a specific vertical | Key Tech |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: Key Tech vs Phillips-Medisize
| Use case | Key Tech fit | Phillips-Medisize fit | Winner |
|---|---|---|---|
| Developing a point-of-care molecular diagnostic instrument and cartridge | Strong | Limited | Key Tech |
| Usability testing for a drug delivery device | Strong | Limited | Key Tech |
| Autoinjector or pen injector development and production | Limited | Strong | Phillips-Medisize |
| Inhaler device for a pharma combination product | Limited | Strong | Phillips-Medisize |
Verdict: Key Tech vs Phillips-Medisize
Key Tech (4.3/5) is the stronger overall choice for most Medical Device Development projects. Designs the diagnostic instrument and its cartridge together, with human factors in the same studio.
Phillips-Medisize (3.9/5) is worth a look if you need inhaler device for a pharma combination product. If your situation matches that, Phillips-Medisize is a competitive option.
Related comparisons
Key Tech vs Phillips-Medisize FAQ
Is Key Tech better than Phillips-Medisize?
Key Tech (4.3/5) scores higher overall, but "better" depends on your use case. Key Tech's strongest advantage: strong record in diagnostics where instrument, consumable and assay have to be developed together. Phillips-Medisize's strongest advantage: very large manufacturing footprint across the US, Europe and Asia.
How do Key Tech and Phillips-Medisize differ in pricing?
Key Tech uses time and materials, phased fixed project pricing. Phillips-Medisize uses development contract plus manufacturing supply agreement pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: Key Tech or Phillips-Medisize?
Key Tech is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between Key Tech and Phillips-Medisize?
Key Tech's primary differentiator is: designs the diagnostic instrument and its cartridge together, with human factors in the same studio. Phillips-Medisize's primary differentiator is: Design, molding and assembly of drug delivery devices under one global quality system. They also differ in team size (75–150 vs ~7,000), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Diagnostics & lab devices, Drug delivery vs Drug delivery, Diagnostics & lab devices).
Verify all details directly with each company before making a decision.